Spotex
Product Images NDC 82160-126

2 FDA label images from Pella Pharmaceuticals Co. Ltd · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Spotex (NDC 82160-126). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pella Pharmaceuticals Co. Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Primary Package (Primary Package)

Primary Package (Primary Package)
Spotex Erythromycin 4% gel packaging label showing the product name and strength prominently. The label indicates the gel's weight as 30 grams and states 'RX ONLY.' The active ingredient is erythromycin at 4%, with 40 mg per gram. Manufactured by Pella Pharmaceuticals Co. Ltd Jordan, the label includes storage instructions below 25°C and a note for topical use only.*
FDA Label Image

Secondary Package (Secondary Package)

Secondary Package (Secondary Package)
Spotex Gel 30g packaging label by Pella Pharmaceuticals Co. Ltd. The label highlights the active ingredient Erythromycin 4% and specifies the dosage form as gel. The design features a light blue background with a pattern and includes branding elements, barcode, and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.